Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Minor

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Expert Review of Molecular Diagnostics|September 10, 2011
Molecular diagnostics: harmonization through reference materials, documentary standards and proficiency testingMarcia J Holden, Roberta M Madej, Philip Minor, et al.
Vaccine|July 19, 2015
In vitro and in vivo growth alter the population dynamic and properties of a Jeryl Lynn mumps vaccineSarah M Connaughton, Jun X Wheeler, Eva Vitková, et al.
Vaccine|June 13, 2006
Potency assay design for adjuvanted recombinant proteins as malaria vaccinesBirgitte K Giersing, Filip Dubovsky, Allan Saul, et al.
The Lancet. Microbe|November 1, 2021
WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific communityIvana Knezevic, Giada Mattiuzzo, Mark Page, et al.
Vaccine|June 13, 2006
WHO informal consultation on scientific basis for regulatory evaluation of candidate human vaccines from plants, Geneva, Switzerland, 24-25 January 2005Jan Willem van der Laan, Philip Minor, Richard Mahoney, et al.
Vaccine|July 7, 2011
WHO Working Group discussion on revision of the WHO recommendations for the production and control of poliomyelitis vaccines (oral): TRS Nos. 904 and 910. Report of Meeting held on 20-22 July 2010, Geneva, SwitzerlandJavier Martin, Catherine Milne, Philip Minor, et al.
The Journal of Infectious Diseases|February 22, 2019
Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency AssaysLaura Crawt, Eleanor Atkinson, Alison Tedcastle, et al.
Cancer Research|November 17, 2005
Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961Rochelle Cutrone, John Lednicky, Glynis Dunn, et al.
Biologicals : Journal of the International Association of Biological Standardization|March 10, 2012
Investigation of porcine circovirus contamination in human vaccinesSarah M Gilliland, Lindsay Forrest, Heather Carre, et al.
Vaccine|February 6, 2017
Comparison of platform technologies for assaying antibody to Ebola virusDianna E Wilkinson, Mark Page, Giada Mattiuzzo, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Expert Review of Molecular Diagnostics|September 10, 2011
Molecular diagnostics: harmonization through reference materials, documentary standards and proficiency testingMarcia J Holden, Roberta M Madej, Philip Minor, et al.
Vaccine|July 19, 2015
In vitro and in vivo growth alter the population dynamic and properties of a Jeryl Lynn mumps vaccineSarah M Connaughton, Jun X Wheeler, Eva Vitková, et al.
Vaccine|June 13, 2006
Potency assay design for adjuvanted recombinant proteins as malaria vaccinesBirgitte K Giersing, Filip Dubovsky, Allan Saul, et al.
The Lancet. Microbe|November 1, 2021
WHO International Standard for evaluation of the antibody response to COVID-19 vaccines: call for urgent action by the scientific communityIvana Knezevic, Giada Mattiuzzo, Mark Page, et al.
Vaccine|June 13, 2006
WHO informal consultation on scientific basis for regulatory evaluation of candidate human vaccines from plants, Geneva, Switzerland, 24-25 January 2005Jan Willem van der Laan, Philip Minor, Richard Mahoney, et al.
Vaccine|July 7, 2011
WHO Working Group discussion on revision of the WHO recommendations for the production and control of poliomyelitis vaccines (oral): TRS Nos. 904 and 910. Report of Meeting held on 20-22 July 2010, Geneva, SwitzerlandJavier Martin, Catherine Milne, Philip Minor, et al.
The Journal of Infectious Diseases|February 22, 2019
Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency AssaysLaura Crawt, Eleanor Atkinson, Alison Tedcastle, et al.
Cancer Research|November 17, 2005
Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961Rochelle Cutrone, John Lednicky, Glynis Dunn, et al.
Biologicals : Journal of the International Association of Biological Standardization|March 10, 2012
Investigation of porcine circovirus contamination in human vaccinesSarah M Gilliland, Lindsay Forrest, Heather Carre, et al.
Vaccine|February 6, 2017
Comparison of platform technologies for assaying antibody to Ebola virusDianna E Wilkinson, Mark Page, Giada Mattiuzzo, et al.
Pageof 3